Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
4D Path ("the Company"), a company dedicated to personalizing cancer care through their advanced approach to predicting tumor response, is pleased to announce today new clinical data highlighted...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
Presentation to Highlight the Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, May 30, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...
-
May 30, 2024Virtual Press Office and PR Newswire: General Trade show news
In this free webinar, learn about the critical role of imaging biomarkers in characterizing patient eligibility, safety and therapeutic efficacy in Alzheimer's disease (AD) clinical trials....
-
May 30, 2024Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual MeetingVirtual Press Office and PR Newswire: General Trade show news
Presentations Cover Aspen's Autologous iPSC-derived Approach for Neuron Replacement Therapy in Trial for Parkinson's Disease SAN DIEGO and VANCOUVER, BC, May 30, 2024 /PRNewswire/ -- Aspen...